Poland· PL-100207577

Vicebrol Forte

A vinpocetine product containing vinpocetinum, registered in Poland by Biofarm Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.

ATC N06BX18

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVicebrol ForteATCN06BX18REGISTER NO.PL-100207577PACKS LISTED12CHECKEDSeptember 27, 2026

Where it is registered

Vinpocetine is registered in 3 of 19 countries.

Countries holding a registration under ATC N06BX18 (vinpocetine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Vinpocetine · ATC N06BX18

3 / 19 countries

  • Czechiaprice
  • Polandprice
  • Spainprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Vinpocetinum
Manufacturer
Biofarm Sp. z o.o.
Country
Poland (PL)
ATC code
N06BX18
ATC class
Vinpocetine
Defined daily dose
15 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 12

  • gtin
    05909990692484
  • gtin
    05909990692408
  • gtin
    05909990692439
  • gtin
    05909990692446
  • gtin
    05909990692460
  • gtin
    05909990692453
  • gtin
    05909990692477
  • gtin
    05909990692507
  • gtin
    05909990692491
  • gtin
    05909990692521
  • gtin
    05909990692538
  • gtin
    05907695215236

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Vinpocetine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vinpocetine products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Bulgaria · Vinpocetine Covex, Винпекс
  • Czechia · Cavinton, Cavinton Forte
  • Spain · Vinpocetina Covex
  • Hungary · Cavinton, Cavinton Forte
  • Lithuania · Cavinton, Cavinton Forte
  • Latvia · Cavinton, Cavinton Forte
  • Portugal · Cavinton, Cerbiotiv
  • Romania · Cavinton, Cavinton Forte
  • Slovenia · Vinpocetin Covex, Vinpocetine Covex
  • Slovakia · Cavinton, Cavinton Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/25ae92d6-fd21-4e23-9f80-92b7365f9d28
GET /v1/drugs/25ae92d6-fd21-4e23-9f80-92b7365f9d28?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909990692408 ¦ Rp ¦ 49411\n10 tabl.\n05909990692439 ¦ Rp ¦ 49412\n30 tabl. (3 x 10)\n05909990692446 ¦ Rp ¦ 49413\n30 tabl. (1 x 30)\n05909990692460 ¦ Rp ¦ 49414\n50 tabl. (5 x 10)\n05909990692453 ¦ Rp ¦ 49415\n50 tabl. (2 x 25)\n05909990692484 ¦ Rp ¦ 49416\n60 tabl. (6 x 10)\n05909990692477 ¦ Rp ¦ 49417\n60 tabl. (2 x 30)\n05909990692507 ¦ Rp ¦ 49418\n90 tabl. (9 x 10)\n05909990692491 ¦ Rp ¦ 49419\n90 tabl. (3 x 30)\n05909990692521 ¦ Rp ¦ 49420\n100 tabl. (10 x 10)\n05909990692538 ¦ Rp ¦ 49421\n100 tabl. (4 x 25)\n05907695215236 ¦ Rp ¦ 113556\n180 tabl.",
  "substance": "Vinpocetinum 10 mg",
  "common_name": "Vinpocetinum",
  "pl_product_id": "100207577",
  "pozwolenie_nr": "15280",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about vinpocetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.